Fintel reports that on May 8, 2025, Barclays upgraded their outlook for Certara (NasdaqGS:CERT) from Equal-Weight to ...

Q1 2025 Earnings Call Transcript May 5, 2025 Certara, Inc. beats earnings expectations. Reported EPS is $0.14, expectations ...

Certara Inc (CERT) reports a robust 10% revenue growth and unveils strategic advancements, while navigating industry ...

William Feehery; Chief Executive Officer, Director; Certara Inc. John Gallagher; Chief Financial Officer; Certar ...

Q1 2025 Results Conference Call May 5, 2025 5:00 PM ETCompany ParticipantsDavid Deuchler - Investor Relations, Gilmartin ...

Discover key Q1 2025 insights from Certara, Inc., including 10% revenue growth, biosimulation advancements, AI integration, and strategic innovations ...

Certara, Inc. reports Q1 2025 revenue of $106 million, a 10% increase, with net income of $4.7 million. Certara, Inc. reported strong financial results for the first quarter of fiscal 2025 ...

Fintel reports that on May 8, 2025, Barclays upgraded their outlook for Certara (NasdaqGS:CERT) from Equal-Weight to Overweight. As of May 6, 2025, the average one-year price target for Certara is ...

Certara Inc. (NASDAQ:CERT), a biosimulation company with a market capitalization of $2.06 billion, reported robust financial results for the first quarter of 2025, surpassing analyst expectations ...

Tuesday, Certara Inc . (NASDAQ:CERT) maintained its Market Perform rating from JMP Securities following the company’s first-quarter earnings report. According to InvestingPro data, the company ...

The projected fair value for Certara is US$8.98 based on 2 Stage Free Cash Flow to Equity Current share price of US$11.37 suggests Certara is potentially 27% overvalued Analyst price target for CERT ...